Eargo, Inc. financial data

Industry
Orthopedic, Prosthetic & Surgical Appliances & Supplies
Location
2665 North First Street, Suite 300, San Jose, CA
State of incorporation
DE
Fiscal year end
December 31
Latest financial report
10-Q - Q3 2023 - Nov 7, 2023

Key Ratios

Label TTM Value / Value Unit Change %
Current Ratio 388 % +241%
Quick Ratio 22.2 % +309%
Debt-to-equity 40.2 % -92.8%
Return On Equity -150 % +79.8%
Return On Assets -107 % +5.42%
Operating Margin -220 %

Shares

Label TTM Value / Value Unit Change %
Entity Common Stock, Shares Outstanding 20.8M shares -47.3%
Common Stock, Shares, Outstanding 20.8M shares -47.3%
Entity Public Float 22.6M USD -97.9%
Common Stock, Value, Issued 2K USD -50%
Weighted Average Number of Shares Outstanding, Basic 20.8M shares +954%
Weighted Average Number of Shares Outstanding, Diluted 20.8M shares +954%

Income Statement

Label TTM Value / Value Unit Change %
Revenue from Contract with Customer, Excluding Assessed Tax 41.1M USD +4.58%
Research and Development Expense 18.8M USD -17%
Selling and Marketing Expense 51M USD -14.9%
General and Administrative Expense 37M USD -39.4%
Operating Income (Loss) -90.4M USD +32.1%
Nonoperating Income (Expense) -17.6M USD +32.4%
Income (Loss) from Continuing Operations before Income Taxes, Noncontrolling Interest -108M USD +32.1%
Net Income (Loss) Attributable to Parent -108M USD +32.1%
Earnings Per Share, Basic 15 USD/shares +96.8%
Earnings Per Share, Diluted 15 USD/shares +96.8%

Balance Sheet

Label TTM Value / Value Unit Change %
Cash and Cash Equivalents, at Carrying Value 46M USD -47.7%
Accounts Receivable, after Allowance for Credit Loss, Current 1.01M USD -12.5%
Inventory, Net 4.39M USD -11.4%
Other Assets, Current 740K USD +77.5%
Assets, Current 56.7M USD -42.9%
Property, Plant and Equipment, Net 4.38M USD -49.6%
Operating Lease, Right-of-Use Asset 7.33M USD +15.6%
Intangible Assets, Net (Excluding Goodwill) 744K USD -38.9%
Goodwill 873K USD 0%
Other Assets, Noncurrent 606K USD +189%
Assets 69.8M USD -40.2%
Accounts Payable, Current 5.05M USD -21.1%
Accrued Liabilities, Current 6.82M USD -37.8%
Liabilities, Current 17.6M USD -88%
Operating Lease, Liability, Noncurrent 7.03M USD +13.8%
Liabilities 24.6M USD -83.9%
Retained Earnings (Accumulated Deficit) -579M USD -23%
Stockholders' Equity Attributable to Parent 45.1M USD
Liabilities and Equity 69.8M USD -40.2%

Popular Metrics

Label TTM Value / Value Unit Change %
Net Cash Provided by (Used in) Operating Activities -21.3M USD -4.82%
Net Cash Provided by (Used in) Financing Activities 24K USD -79.7%
Net Cash Provided by (Used in) Investing Activities -132K USD +86%
Common Stock, Shares Authorized 450M shares +50%
Common Stock, Shares, Issued 20.8M shares -47.3%
Common Stock, Par or Stated Value Per Share 0 USD/shares 0%
Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents, Period Increase (Decrease), Including Exchange Rate Effect -21.5M USD -0.91%
Deferred Tax Assets, Valuation Allowance 103M USD +28.3%
Deferred Tax Assets, Gross 105M USD +26.1%
Operating Lease, Liability 7.65M USD +11.9%
Payments to Acquire Property, Plant, and Equipment 102K USD -85.1%
Lessee, Operating Lease, Liability, to be Paid 9.93M USD +11.9%
Property, Plant and Equipment, Gross 20.5M USD -0.43%
Operating Lease, Liability, Current 624K USD -6.17%
Lessee, Operating Lease, Liability, to be Paid, Year Two 1.64M USD +51.2%
Lessee, Operating Lease, Liability, to be Paid, Year One 1.08M USD -2.96%
Operating Lease, Weighted Average Discount Rate, Percent 0.08 pure
Lessee, Operating Lease, Liability, Undiscounted Excess Amount 2.28M USD +12.1%
Lessee, Operating Lease, Liability, to be Paid, Year Three 1.89M USD +41.7%
Deferred Tax Assets, Operating Loss Carryforwards 91M USD +46.1%
Preferred Stock, Shares Issued 0 shares
Preferred Stock, Shares Authorized 5M shares 0%
Unrecognized Tax Benefits 1.32M USD -39.9%
Lessee, Operating Lease, Liability, to be Paid, Year Four 1.95M USD +41.8%
Preferred Stock, Shares Outstanding 0 shares
Amortization of Intangible Assets 300K USD -50%
Depreciation, Depletion and Amortization 5.32M USD +8.09%
Deferred Tax Assets, Net of Valuation Allowance 2.11M USD -31.2%
Share-based Payment Arrangement, Expense 8.98M USD -53.8%
Interest Expense 1.09M USD -16.7%
Preferred Stock, Par or Stated Value Per Share 0 USD/shares 0%